Related Experiment Video
Updated: Nov 10, 2025
06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
13.1K
[Antitumor Immunity Evaluated via the Peripheral Blood].
1Division of Respiratory Medicine, Saitama Medical University International Medical Center.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 2021
Summary
Antitumor immunity relies on both CD8+ and CD4+ T cells, which circulate in peripheral blood. Understanding their migration is key to cancer immunity cycle theories and effective immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- Cancer immune-editing and cancer immunity cycle theories explain antitumor T-cell immunity development.
- Both CD8+ and CD4+ T cells are crucial for establishing antitumor immunity.
- Antitumor T cells are widely distributed, including in peripheral blood.
Purpose of the Study:
- To discuss antitumor immunity by examining the role of peripheral blood circulation.
- To explore the mechanisms of action for anti-PD-1/PD-L1 and anti-CTLA-4 antibodies.
Main Methods:
- Review of recent studies on T cell phenotypes and clonotypes in antitumor immunity.
- Analysis of the cancer immunity cycle, focusing on the peripheral blood migration step.
- Discussion of immunotherapeutic mechanisms involving immune checkpoint inhibitors.
Main Results:
- Peripheral blood serves as a critical pathway for delivering primed antitumor T cells.
- T cell migration and invasion via peripheral blood are integral to the cancer immunity cycle.
- Understanding T cell distribution enhances insights into immunotherapeutic efficacy.
Conclusions:
- Peripheral blood T cell dynamics are fundamental to antitumor immune responses.
- Immune checkpoint inhibitors like anti-PD-1/PD-L1 and anti-CTLA-4 leverage T cell circulation.
- Further research into T cell trafficking can optimize cancer immunotherapy strategies.
